VLAD SANDULACHE to Oropharyngeal Neoplasms
This is a "connection" page, showing publications VLAD SANDULACHE has written about Oropharyngeal Neoplasms.
Connection Strength
4.947
-
Recurrent Oropharyngeal Squamous Cell Carcinomas Maintain Anti-tumor Immunity and Multinucleation Levels Following Completion of Radiation. Head Neck Pathol. 2023 Dec; 17(4):952-960.
Score: 0.483
-
Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients. Oral Oncol. 2023 Aug; 143:106459.
Score: 0.468
-
Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration. Mod Pathol. 2022 08; 35(8):1045-1054.
Score: 0.428
-
Consistent multimodality approach to oral cavity and high-risk oropharyngeal cancer in veterans. Am J Otolaryngol. 2021 Nov-Dec; 42(6):103166.
Score: 0.411
-
Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma. BMC Cancer. 2020 Sep 23; 20(1):912.
Score: 0.388
-
CD8 infiltration is associated with disease control and tobacco exposure in intermediate-risk oropharyngeal cancer. Sci Rep. 2020 01 14; 10(1):243.
Score: 0.370
-
Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based Meeting. Oral Oncol. 2020 03; 102:104440.
Score: 0.364
-
Gastrostomy Utilization by Oropharyngeal Cancer Patients Is Partially Driven by Swallowing Function. Laryngoscope. 2020 09; 130(9):2153-2159.
Score: 0.362
-
Swallowing Function in Survivors of Oropharyngeal Cancer Is Associated With Advanced T Classification. Ann Otol Rhinol Laryngol. 2019 Aug; 128(8):696-703.
Score: 0.350
-
Oropharyngeal squamous cell carcinoma in the veteran population: Association with traditional carcinogen exposure and poor clinical outcomes. Head Neck. 2015 Sep; 37(9):1246-53.
Score: 0.270
-
Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival. Head Neck. 2013 Oct; 35(10):1454-60.
Score: 0.223
-
Immunogenetic Determinants of Susceptibility to Head and Neck Cancer in the Million Veteran Program Cohort. Cancer Res. 2023 02 03; 83(3):386-397.
Score: 0.114
-
Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer. 2022 11 01; 128(21):3831-3842.
Score: 0.111
-
Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV-negative veterans. Cancer. 2022 09 15; 128(18):3310-3318.
Score: 0.110
-
An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer. J Natl Cancer Inst. 2022 04 11; 114(4):609-617.
Score: 0.108
-
Incidence and survival for oropharynx and non-oropharynx head and neck cancers among veterans living with HIV. Cancer Med. 2020 12; 9(24):9326-9335.
Score: 0.098
-
National trends in oropharyngeal cancer incidence and survival within the Veterans Affairs Health Care System. Head Neck. 2021 01; 43(1):108-115.
Score: 0.097
-
Prognostic Significance of p16 Cellular Localization in Oropharyngeal Squamous Cell Carcinoma. Ann Clin Lab Sci. 2016; 46(2):132-9.
Score: 0.070
-
Impact of race on oropharyngeal squamous cell carcinoma presentation and outcomes among veterans. Head Neck. 2016 Jan; 38(1):44-50.
Score: 0.066
-
Improving imaging diagnosis of persistent nodal metastases after definitive therapy for oropharyngeal carcinoma: specific signs for CT and best performance of combined criteria. AJNR Am J Neuroradiol. 2013 Aug; 34(8):1637-42.
Score: 0.057